EGFR and lung cancer: Persister cells grow slowly and even enter quiescence in the presence of EGFR‐TKIs, and are responsible for MRD that eventually leads to recurrence.[16] Therefore, we constructed an orthotopic lung cancer model using LLC/2 cells to monitor the efficacy of the combination treatment against recurrent tumor growth.